David Shaw’s CG Oncology CGON Stock Holding History
Bought
Maintained
Sold
Other funds holding CGON
David Shaw's CGON Position: Q3 2026 in Review
David Shaw increased its CG Oncology (CGON) stake by 11% in Q3 2026, buying an estimated $699K and bringing the position to 98,930 shares worth $7.01M. The position accounts for ﹤0.01% of the portfolio, ranked #2150.
David Shaw first reported a position in CGON in Q2 2025 and has held it in 6 quarters since. 233 funds tracked by Wall St. Rank hold CGON as of Q3 2026.
- David Shaw held 98,930 shares of CG Oncology worth $7.01M as of Q3 2026.
- David Shaw bought 9,513 CG Oncology shares in Q3 2026, an estimated $699K.
- CG Oncology made up ﹤0.01% of David Shaw's portfolio in Q3 2026, its #2150 holding.
- David Shaw first reported a position in CG Oncology in Q2 2025 and has held it in 6 quarters since.
- 233 funds tracked by Wall St. Rank held CG Oncology as of Q3 2026.
Based on D.E. Shaw & Co's 13F filing for Q3 2026, filed 16 Nov 2026.